Please login to the form below

Not currently logged in
Email:
Password:

Alexza’s Peter Schineller joins Agendia

Appointed first chief commercial officer

Agendia Peter SchinellerCancer diagnostics firm Agendia has appointed Peter Schineller as its first chief commercial officer.

Schineller's appointment marks a swift departure from his previous role at Alexza Pharmaceuticals, which he only joined in March 2013 as senior VP and chief commercial officer.

He has additional healthcare experience as general manager at Roche subsidiary Ventana Medical Systems and as senior VP for sales, marketing and commercial operations at Genoptix Medical Laboratories, a diagnostic firm that was acquired by Novartis.

David Macdonald, Agendia's CEO, explained the creation of the new commercial role: "As we continue our growth momentum into 2013, we are committed to building out a world class organisation capable of managing and growing a much larger company.

"Mr Schineller's depth of experienced senior leadership of global commercial organisations will help us perpetuate our volume growth, which exceeded 140 percent in 2012."

5th June 2013

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Virgo Health

Virgo Health is an award-winning global healthcare communications and medical education agency. We dispense pioneering and creative campaigns, driven by...

Latest intelligence

Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
Pharma M&A
Pharma funding and M&A in 2020
Why pharma M&A has continually bucked the trend...
Behaviour change through medical education: How can we turn aspiration into reality?
Practical, evidence-based insights into a CME process that aims to effect measurable behaviour change...

Infographics